Published in Gynecol Oncol on August 01, 2015
Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review. J Immunol Res (2017) 0.75
Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma. World J Gastroenterol (2016) 0.75
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Human papillomavirus and cervical cancer. Lancet (2007) 12.47
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet (2001) 7.31
The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev (1999) 5.49
Papillomaviruses in the causation of human cancers - a brief historical account. Virology (2009) 5.46
Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst (2009) 3.58
Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine (2006) 2.51
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer (2004) 2.46
Immune responses to human papillomavirus. Vaccine (2006) 2.37
Host and viral genetics and risk of cervical cancer: a review. Virus Res (2002) 1.97
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res (2004) 1.90
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res (2001) 1.89
WHIM syndrome: congenital immune deficiency disease. Curr Opin Hematol (2009) 1.85
Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst (1997) 1.72
Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol (2001) 1.61
Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res (2008) 1.40
Snagger: a user-friendly program for incorporating additional information for tagSNP selection. BMC Bioinformatics (2008) 1.35
Targeting the development and effector functions of TH17 cells. Semin Immunol (2008) 1.29
Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis. Hum Immunol (2009) 1.27
Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst (2013) 1.22
The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin Exp Immunol (1999) 1.21
GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling. Oncogene (2007) 1.21
The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev (1996) 1.17
Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomarkers Prev (2001) 1.14
Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach. Int J Cancer (2009) 1.11
Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han women with breast cancer. PLoS One (2012) 1.11
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet (2013) 1.09
HPV-related cancers after solid organ transplantation in the United States. Am J Transplant (2013) 1.03
Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection. Cancer Epidemiol Biomarkers Prev (2010) 1.02
Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin Cancer Res (2009) 1.00
Association between IL17 polymorphisms and risk of cervical cancer in Chinese women. Clin Dev Immunol (2012) 0.98
Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster. Cancer Epidemiol Biomarkers Prev (2010) 0.95
Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2. Cancer Epidemiol Biomarkers Prev (2008) 0.94
Genetic variants and risk of cervical cancer: epidemiological evidence, meta-analysis and research review. BJOG (2014) 0.94
IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia. J Immunol (2014) 0.89
Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study. Int J Cancer (2013) 0.89
Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: a population-based case-control study. Int J Cancer (2013) 0.81
Genetic variants in interleukin-18 gene and risk for cervical squamous cell carcinoma. Hum Immunol (2013) 0.80
Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma. Front Oncol (2014) 0.78